Cargando…

Prevention and Treatment of Corticosteroid-Induced Osteoporosis

Osteoporosis is one of the most serious complications of corticosteroid treatment. Loss of bone mineral density (BMD) and fractures occur early in the course of corticosteroid treatment, and thus early recognition of fracture risk and effective intervention based on evidence-based-medicine (EBM) are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwamoto, Jun, Takeda, Tsuyoshi, Sato, Yoshihiro
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2005
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815828/ https://www.ncbi.nlm.nih.gov/pubmed/16127768 http://dx.doi.org/10.3349/ymj.2005.46.4.456

Ejemplares similares

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
por: Iwamoto, Jun, et al.
Publicado: (2008)

Effects of Vitamin K(2) on the Development of Osteopenia in Rats as the Models of Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2006)

Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2005)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2010)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)

Understanding and Managing Corticosteroid-Induced Osteoporosis
por: Kobza, Alexandra O, et al.
Publicado: (2021)

Efficacy of Oral Etidronate for Skeletal Diseases in Japan
por: Iwamoto, Jun, et al.
Publicado: (2005)

Effects of Risedronate on Osteoarthritis of the Knee
por: Iwamoto, Jun, et al.
Publicado: (2010)

Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2022)

Return to play after conservative treatment in athletes with symptomatic lumbar disc herniation: a practice-based observational study
por: Iwamoto, Jun, et al.
Publicado: (2011)

Retraction: Effect of Treadmill Exercise on Bone Mass in Female Rats
por: IWAMOTO, Jun, et al.
Publicado: (2022)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Managing Corticosteroid Induced Osteoporosis in Medical Outpatients
por: Bell, Rebecca, et al.
Publicado: (1997)

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
por: Iwamoto, Jun, et al.
Publicado: (2011)

Serum Leptin Concentration Positively Correlates with Body Weight and Total Fat Mass in Postmenopausal Japanese Women with Osteoarthritis of the Knee
por: Iwamoto, Jun, et al.
Publicado: (2011)

Minodronate for the treatment of osteoporosis
por: Ohishi, Tsuyoshi, et al.
Publicado: (2018)

Retraction: Effect of Pre- and Post-Surgery Treatment with Risedronate on Trabecular Bone Loss in Ovariectomized Rats
por: IWAMOTO, Jun, et al.
Publicado: (2018)

Influence of treatment with alendronate on the speed of sound, an ultrasound parameter, of the calcaneus in postmenopausal Japanese women with osteoporosis: a clinical practice-based observational study
por: Iwamoto, Jun, et al.
Publicado: (2012)

Retraction: Preventive effects of risedronate and calcitriol on cancellous osteopenia in ratstreated with high-dose glucocorticoid
por: IWAMOTO, Jun, et al.
Publicado: (2019)

Retraction: Additive effect of vitamin K(2) and risedronate on long bone mass in hypophysectomized young rats
por: IWAMOTO, Jun, et al.
Publicado: (2019)

Retraction: Response of cortical and cancellous bones to mild calcium deficiency in young growing female rats: a bone histomorphometry study
por: IWAMOTO, Jun, et al.
Publicado: (2019)

Self-reported osteoporosis prevention in inhaled corticosteroid users in community pharmacy setting
por: Chan, Valerie, et al.
Publicado: (2015)

Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures
por: Iwamoto, Jun, et al.
Publicado: (2012)

Src siRNA prevents corticosteroid-associated osteoporosis in a rabbit model
por: Zheng, Li-Zhen, et al.
Publicado: (2016)

A Radiographic Study on the Associations of Age and Prevalence of Vertebral Fractures with Abdominal Aortic Calcification in Japanese Postmenopausal Women and Men
por: Iwamoto, Jun, et al.
Publicado: (2009)

Vitamin K(2) Therapy for Postmenopausal Osteoporosis
por: Iwamoto, Jun
Publicado: (2014)

Seven years’ experience with etidronate in a woman with anorexia nervosa and vertebral fractures
por: Iwamoto, Jun, et al.
Publicado: (2011)

Corticosteroid use in chronic dermatologic disorders and osteoporosis
por: Lupsa, Beatrice C., et al.
Publicado: (2021)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

A review of denosumab for the treatment of osteoporosis
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2014)

Corticosteroids and ARDS: A review of treatment and prevention evidence
por: Khilnani, G.C., et al.
Publicado: (2011)

Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia
por: Bulbul, Ali, et al.
Publicado: (2023)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011)

Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010)

Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses
por: Florez, Helena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_590l4aet1sskvr5vn4l6o5g3b9